![]() |
Nouvelles sur le tabagisme de Stop-tabac.ch Préparées par Jean-François Etter Le 27 Novembre 2007 |
- Royaume Uni : La modification du Code de la Route considère le fait de fumer au volant comme une distraction
- On va faire le trottoir pour fumer !
- USA: New study suggests that low-nicotine cigarettes could help smokers quit
Royaume Uni : La modification du Code de la Route considère le fait de fumer au volant comme une distraction
D'après le Code de la Route qui vient d'être révisé et qui devrait
s'appliquer à partir du 28 septembre 2007, avoir une cigarette en
conduisant constitue une infraction aux règles de conduite et est
classé dans la catégorie distraction . Ceci signifie qu'un conducteur
qui a un accident alors qu'il fume peut être poursuivi pour conduite
sans prudence ni attention et encourir de ce fait une amende de 2 500 ,
soit environ 3 600 Euros, à laquelle s'ajoutent trois points de
pénalité sur les neuf points disponibles voire un retrait pur et simple
du permis. Ce changement est techniquement considéré comme l'adoption
des meilleures pratiques en matière de prévention routière.
Source : Nouvelles du CNCT et
Telegraph !
http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2007/09/28/nsmoke128.xml
On va faire le trottoir pour fumer !
Alors
que plus de 10 000 buralistes manifestent contre l'interdiction de
fumer dans les bars au 1er janvier, qu'en pensent les premiers
intéressés, clients et barmans ? Ambiance dans les troquets parisiens.
Lire la suite (Libération):
http://www.liberation.fr/actualite/societe/292839.FR.php
USA: New study suggests that low-nicotine cigarettes could help smokers quit
A new study suggests that forcing tobacco companies to cut the level of
nicotine in cigarettes can help smokers shake off their addiction.
It was assumed that low nicotine cigarettes would simply encourage
people to smoke more. Instead, a quarter of those taking part in the
study quit smoking completely, while others reduced the number of
cigarettes they smoked by more than a third.
Experts had
feared a reduced nicotine strategy would be self-defeating, since
increasing the numbers of cigarettes smokers would then be exposed to
even greater levels of dangerous tobacco chemicals.
This is
already known to occur with so called mild cigarette brands which
contain normal nicotine levels, but are engineered to burn faster and
have ventilation holes above the filter.
The new findings provide support for plans now under discussion in Congress to allow tob!
acco products to be regulated in the US in the same way as medicines.
Under the proposals, the US Food and Drink Administration (FDA) would
be empowered to develop and enforce standards designed to make
cigarettes safer, which could include reducing nicotine yields so that
cigarettes are less addictive.
In the study, adult smokers
were asked to smoke their usual brand for a week. They were then put on
a six week regimen of smoking cigarettes with progressively lower
levels of nicotine. At the end of the six weeks, they were free to
return to their usual brand and most did. But tested a month later,
they were smoking forty per cent fewer cigarettes per day than they did
before the study. Furthermore, a quarter of the smokers quit their
habit entirely while the study was in progress.
Professor
Neal Benowitz, who led the research team from the University of
California at San Francisco, said: "This study supports the idea that
if tobacco companies ! were required to reduce the levels of nicotine
in cigarette to! bacco, y
oung people who start smoking could avoid becoming addicted, and
current smokers could reduce or end their smoking." Source: ASH daily
news (www.ash.org.uk) and Channel 4, 14 November 2007
Link: http://tinyurl.com/2vbdze
Gratuit: brochures, affiches et autocollants
Vous pouvez retrouver ces nouvelles sur le tabagisme tous les jours sur:
http://www.stoptabac.ch/fr/news.html
Si vous ne désirez plus recevoir ces nouvelles, cliquez simplement ici
Stop-tabac.ch est un programme de l’Institut de Médecine Sociale et Préventive de la Faculté de Médecine de l’Université de Genève, financé par le Département de l’Economie et de la Santé (Genève, Suisse).


















